Fig. 1
From: SARS-COV-2 vaccine responses in renal patient populations
Differences in SARS-CoV-2 antibody responses in three immunocompromised patient populations. A Antibody responses following first and second vaccine dose by group. B Antibody responses by group and vaccine type. Panels show log MFI of SARS-CoV-2 spike protein IgG antibody responses sampled median x days following first vaccine dose and x days after second dose of vaccine. The positive threshold (IgG antibody titre 1896, log MFI 7.55) is indicated by the horizontal dotted line. The bars represent medians and interquartile ranges and dots represent individual patient results